Shareholders' Deficit

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders' Deficit

Under the authority of our Board of Directors, we repurchased shares of our Common Stock during the quarters ended March 31, 2023 and 2022 as indicated below.  All amounts exclude applicable transaction fees. 

	Shares Repurchased (thousands)			Dollar Value of Shares Repurchased					Remaining Dollar Value of Shares that may be Repurchased
Authorization Date	2023	2022		2023		2022			2023
May 2021	—	3,359		—		407			—
September 2022	387	—		50		—			1,700
Total	387	3,359	(a)	$	50	$	407	(a)	$	1,700

(a)    2022 amount includes the effect of $64 million in share repurchases (0.5 million shares) with trade dates on, or prior to, March 31, 2022, but cash settlement dates subsequent to March 31, 2022.

In September 2022, our Board of Directors authorized share repurchases of up to $2 billion (excluding applicable transaction fees) of our outstanding Common Stock through June 30, 2024. As of March 31, 2023, we have remaining capacity to repurchase up to $1.7 billion of Common Stock under the September 2022 authorization.

Changes in Accumulated other comprehensive loss (“AOCI”) are presented below.

	Translation Adjustments and Gains (Losses) From Intra-Entity Transactions of a Long-Term Nature		Pension and Post-Retirement Benefits		Derivative Instruments		Total
Balance at December 31, 2022, net of tax	$	(290)	$	(94)	$	15	$	(369)
OCI, net of tax
Gains (losses) arising during the period classified into AOCI, net of tax	8		(2)		(6)		—
(Gains) losses reclassified from AOCI, net of tax	—		—		(2)		(2)
	8		(2)		(8)		(2)
Balance at March 31, 2023, net of tax	$	(282)	$	(96)	$	7	$	(371)